NCT03964623

Brief Summary

The main hypothesis is the nicotine is associated with a modification of retinal micro-vascularization. Patients will be recruited during their ophthalmologic consultation at the Rothschild Foundation, an OCT-A will be realized and data relating to medical history, oral contraceptive intake and nicotine consumption via cigarette or e-cigarette data will be collected. The objective is to seek an association between retinal vascular density and inhaled nicotine intake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 28, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

July 17, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2022

Completed
Last Updated

February 17, 2023

Status Verified

February 1, 2023

Enrollment Period

3.4 years

First QC Date

May 24, 2019

Last Update Submit

February 16, 2023

Conditions

Keywords

OCT-Asmokersvapersnon-smokers/non-vapersnicotineretinal micro-vascularization

Outcome Measures

Primary Outcomes (1)

  • Density of retinal vascular Plexus (quantitative variable expressed as a percentage) using OCT-A.

    At the inclusion consultation

Study Arms (3)

smokers

Diagnostic Test: OCT-A (Optical Coherence Tomography)

vapers

Diagnostic Test: OCT-A (Optical Coherence Tomography)

non smokers/non vapers

Diagnostic Test: OCT-A (Optical Coherence Tomography)

Interventions

Included patients will have an OCT-A and will be questioned about their nicotine intake, their background and taking an oral conception

non smokers/non vaperssmokersvapers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People presenting to an ophthalmologic consultation at the Foundation Rothschild will be included in one of the 3 groups: smokers, non-smokers/non-vapers or vapers if they meet the inclusion and non-inclusion criteria

You may qualify if:

  • For group of smokers: Patient reporting active smoking for at least 3 months and at least 1 cigarette per day on average over a week
  • For group of vapers : Patient using exclusively the electronic cigarette with a nicotine level of more than 6mg/ml for at least 3 months and at least 1 times per day on average over a week.
  • For group of no-smokers no-vapersNon-smoking and no vaping, for more than 6 months
  • Caffeine intake within 2 hours prior to the OCT-A exam
  • ametropia greater than + 3 dioptres of hyperopia or-3 dioptres of myopia
  • astigmatism greater than 2 dioptres
  • Known retinal or retina vascular pathology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation A de Rothschild

Paris, 75019, France

Location

MeSH Terms

Interventions

Tomography, Optical Coherence

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2019

First Posted

May 28, 2019

Study Start

July 17, 2019

Primary Completion

December 2, 2022

Study Completion

December 2, 2022

Last Updated

February 17, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations